Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...
HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...
This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...
STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital is among the first in the country to successfully treat persistent atrial fibrillation and typical atrial flutter using a ...
Key takeawaysAn international panel of more than 80 experts has issued updated guidance to improve care for atrial fibrillation (AF) patients ...
You may have heard the phrase "my heart skipped a beat" when someone was talking about a romantic encounter. In truth, hearts that beat irregularly are dangerous for your health. Atrial fibrillation ...
Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.
News-Medical.Net on MSN
Imaging-enhanced knowledge graphs reveal new targets for heart disease treatment
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback